From AVAC <[email protected]>
Subject Announcing A New Dynamic Global PrEP Tracker
Date July 16, 2020 10:59 AM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
** Announcing A New Dynamic Global PrEP Tracker
------------------------------------------------------------
July 16, 2020

Dear Advocate,

AVAC is excited to share a whole new way to visualize and explore the data from our Global PrEP Tracker, a database that documents oral PrEP uptake around the world. This new tool is now live at data.prepwatch.org. This new site provides a tool for visualizing oral PrEP data, which AVAC has collected every quarter since 2016.


With our data visualization tool, you can see how oral PrEP uptake is growing by country and across the globe, compare progress by region and over time, and see which countries are leading delivery. Data are updated quarterly from surveys of programs, demonstration projects, clinical trials, and other oral PrEP initiatives from 78 countries, every country with a known program.

Use the tool for a quick snapshot on oral PrEP trends, and take a deeper dive with the PrEP Tracker in Excel ([link removed]) , which offers a sortable database of information on national programs delivering oral PrEP, country guidelines and targets, drug registration status and more. Don’t see your country or program represented? Please do be in touch with us at [email protected].

You’ll find these resources on PrEPWatch.org, which will help you stay current on oral PrEP data and inform your advocacy for prevention. Effective prevention depends on access to oral PrEP programs now and the ability of those programs to incorporate future products for a world with many options to meet the diverse needs of those who need prevention most.

If you have any questions or additional data you’d like to see reflected here, please reach out to [email protected].

Best,
AVAC

============================================================
NEW RESOURCE

Understanding the Results of HPTN 083Speaking of future PrEP options, be sure to check out our new Advocates' Primer on Long-Acting Injectable Cabotegravir for PrEP.

READ MORE > [link removed]

============================================================
Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe

Contact Us T: +1 212 796 6423
E: ** [email protected]
W: ** www.avac.org
** www.twitter.com/hivpxresearch
** www.facebook.com/hivpxresearch
** www.youtube.com/hivpxresearch
==============================================

Unsubscribe [email protected] from this list:
[link removed]
Screenshot of the email generated on import

Message Analysis